Agenus (AGEN) Gross Margin (2010 - 2026)

Agenus' (AGEN) quarterly Gross Margin came in at 100.0% in Q1 2026, up 57.0% year-on-year from 63.69% in Q1 2025, and up 218.53% quarter-over-quarter from 31.39% in Q4 2025.

Agenus (AGEN) Gross Margin (2010 - 2026) Analysis & Trends

Agenus' Gross Margin history runs 12 years deep, the most recent figure standing at 100.0% for Q1 2026.

  • On a quarterly basis, Gross Margin rose 57.0% year-over-year to 100.0% in Q1 2026; TTM through Mar 2026 was 80.34%, a 895.0% increase from a year earlier, with the FY2025 full-year figure at 78.56%, up 605.0% from the prior year.
  • Gross Margin advanced to 100.0% in Q1 2026 per AGEN's latest filing, from 31.39% in the prior quarter.
  • Across five years, Gross Margin topped out at 117.35% in Q4 2022 and bottomed at 4.61% in Q4 2024.
  • The 5-year median for Gross Margin is 98.75% (2023), against an average of 86.59%.
  • Across the five-year window, Gross Margin tumbled 6302 bps in 2024 and surged 3600 bps in 2025, its largest moves.
  • Year by year, Gross Margin stood at 117.35% in 2022, then sank by 50 bps to 58.41% in 2023, then plunged by 108 bps to 4.61% in 2024, then soared by 782 bps to 31.39% in 2025, then soared by 219 bps to 100.0% in 2026.
  • Per Business Quant, the three latest AGEN Gross Margin figures stand at 100.0% (Q1 2026), 31.39% (Q4 2025), and 97.88% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 88.95%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 86.85%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 91.79%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 90.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Agenus 184.05 Mn 177.29 Mn 33.74 Mn 100.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 100.00%
Dec 31, 2025 31.39%
Sep 30, 2025 97.88%
Jun 30, 2025 99.05%
Mar 31, 2025 99.43%
Dec 31, 2024 -4.61%
Sep 30, 2024 99.42%
Jun 30, 2024 99.51%
Mar 31, 2024 99.62%
Dec 31, 2023 58.41%
Sep 30, 2023 98.75%
Jun 30, 2023 99.00%
Mar 31, 2023 89.98%
Dec 31, 2022 117.35%
Sep 30, 2022 98.65%
Jun 30, 2022 90.33%
Mar 31, 2022 97.91%
Dec 31, 2021 95.65%
Sep 30, 2021 99.68%
Jun 30, 2021 93.78%